Antisense modulation of c-reactive protein expression

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 21/04 (2006.01) A61K 48/00 (2006.01) C12N 15/00 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2454791

Antisense compounds, compositions and methods are provided for modulating the expression of C-reactive protein. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding C-reactive protein. Methods of using these compounds for modulation of C-reactive protein expression and for treatment of diseases associated with expression of C-reactive protein are provided.

L'invention concerne des composés antisens, des compositions et des procédés permettant de moduler l'expression de la protéine réactive C. Les compositions comprennent des composés antisens, en particulier des oligonucléotides antisens ciblés sur des acides nucléiques codant pour la protéine réactive C. L'invention concerne aussi des méthodes d'utilisation de ces composés afin de moduler l'expression de la protéine réactive C et de traitement de maladies associées à l'expression de la protéine réactive C.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antisense modulation of c-reactive protein expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense modulation of c-reactive protein expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of c-reactive protein expression will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2059778

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.